Publications by authors named "Lisa Rodriguez"

Claim this Profile
F
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas.
Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu, Lisa R Rodriguez, Susan Jin

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations.
Arianna Simonetti, Susan Colilla, Brian Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez

Drug Saf· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Collection and Analysis of Overall Survival Data.
Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, Anup K Amatya, George D Demetri

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry.
Martin Gebel, Cheryl Renz, Lisa Rodriguez, Arianna Simonetti, Hong Yang

Ther Innov Regul Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive, behavioral, and emotional outcomes following postoperative pediatric cerebellar mutism syndrome in survivors treated for medulloblastoma.
Kimberly P Raghubar, Andrew M Heitzer, Fatema Malbari, Jason Gill, Roy V Sillitoe, Lisa Rodriguez

J Neurosurg Pediatr· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma.
Deepti Telaraja, Yvette L Kasamon, Justin S Collazo, Ruby Leong, Kun Wang, Lisa R Rodriguez

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reclassification of the p.Ala13Glu variant causing primary hypertrophic osteoarthropathy.
Juan J Alban, Alejandra Arango-Ramirez, Jorge A Olave-Rodriguez, Jose A Nastasi-Catanese, Lisa X Rodriguez

Cold Spring Harb Mol Case Stud· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outbreak management of multidrug-resistant in 16 shelter-housed cats.
Lisa Rodriguez, Elizabeth A Berliner

J Feline Med Surg· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Landscape of Benefit-Risk Considerations for Medicinal Products: Current State and Future Directions.
Max Waschbusch, Lisa Rodriguez, Andreas Brueckner, Kerry Jo Lee, Xuefeng Li

Pharmaceut Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities.
Fatema Malbari, Jason Gill, Amy Daigle, Lisa L Rodriguez, Kimberly P Raghubar

Pediatr Neurol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Blood Flow Patterns and Endothelial Shear Stress at the Carotid Artery Using Different Exercise Modalities and Intensities.
Samuel Montalvo, Manuel Gomez, Alondra Lozano, Sabrina Arias, Lisa Rodriguez

Front Physiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial.
E Dianne Pulte, Haiyan Chen, Lauren S L Price, Ramadevi Gudi, Hongshan Li, Lisa Rodriguez

Oncologist· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
There are no differences in brachial artery endothelial shear stress and blood flow patterns between males and females during exercise.
Alvaro N Gurovich, Lisa Rodriguez, Francisco Morales-Acuna

Clin Physiol Funct Imaging· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib.
May Tun Saung, Lorraine Pelosof, Sandra Casak, Martha Donoghue, Steven Lemery, Lisa Rodriguez

Oncologist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors.
Leigh Marcus, Lola A Fashoyin-Aje, Martha Donoghue, Mengdie Yuan, Lisa Rodriguez

Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non-small Cell Lung Cancer, A Collaborative Project Orbis Review.
Paz J Vellanki, Flora Mulkey, Adnan A Jaigirdar, Lisa Rodriguez, Yibo Wang

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, Erin Larkins, Jonathon Vallejo, Lisa Rodriguez

Oncologist· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma.
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, Xiaoping Jiang, Lisa Rodriguez

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with Gene Mutations or Fusions.
Diana Bradford, Erin Larkins, Sirisha L Mushti, Lisa Rodriguez, Amy M Skinner

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma.
Abhilasha Nair, Kelie Reece, Martha B Donoghue, Weishi Vivian Yuan, Lisa Rodriguez

Oncologist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An endothelial growth factor receptor compound mutation of T790M substitution with exon 19 deletion in a previously untreated patient: a case report.
Juan C Falla-Martinez, Daniela Espinosa, Juan C Baena, Lisa X Rodriguez, Luz F Sua

J Med Case Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA's Approval of the First Biosimilar to Bevacizumab.
Sandra J Casak, Steven J Lemery, Jee Chung, Chana Fuchs, Sarah J Schrieber, Lisa Rodriguez

Clin Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring Mutations.
Lauretta Odogwu, Luckson Mathieu, Gideon Blumenthal, Erin Larkins, Kirsten B Goldberg, Lisa Rodriguez

Oncologist· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on Sorafenib.
Lorraine Pelosof, Steven Lemery, Sandra Casak, Xiaoping Jiang, Lisa Rodriguez

Oncologist· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation.
Lauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, Gideon M Blumenthal, Erin Larkins, Lisa Rodriguez

Oncologist· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis